Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 3
2007 2
2008 1
2009 1
2011 4
2013 5
2014 5
2015 6
2016 5
2017 5
2018 5
2019 6
2020 4
2021 4
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Acute gefitinib-induced pneumonitis.
Ohyanagi F, Ando Y, Nagashima F, Narabayashi M, Sasaki Y. Ohyanagi F, et al. Int J Clin Oncol. 2004 Oct;9(5):406-9. doi: 10.1007/s10147-004-0418-0. Int J Clin Oncol. 2004. PMID: 15549594
Immunoglobulin G4-related Pleuritis Complicated with Minimal Change Disease.
Mizushina Y, Shiihara J, Nomura M, Ohta H, Ohyanagi F, Morishita Y, Tsubochi H, Tanaka A, Yamaguchi Y. Mizushina Y, et al. Among authors: ohyanagi f. Intern Med. 2022 Mar 1;61(5):723-728. doi: 10.2169/internalmedicine.7010-20. Epub 2021 Sep 4. Intern Med. 2022. PMID: 34483205 Free PMC article.
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).
Uematsu S, Kitazono S, Tanaka H, Saito R, Kawashima Y, Ohyanagi F, Tozuka T, Ryosuke T, Sakatani T, Horiike A, Yoshizawa T, Saiki M, Tambo Y, Koyama J, Kanazu M, Kudo K, Tsuchiya-Kawano Y, Yanagitani N, Nishio M. Uematsu S, et al. Among authors: ohyanagi f. Thorac Cancer. 2023 Jan;14(2):168-176. doi: 10.1111/1759-7714.14729. Epub 2022 Nov 21. Thorac Cancer. 2023. PMID: 36408699 Free PMC article.
Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab.
Kawashima Y, Nishikawa S, Ninomiya H, Yoshida R, Takano N, Oguri T, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Ishikawa Y, Nishio M. Kawashima Y, et al. Among authors: ohyanagi f. Intern Med. 2019;58(10):1479-1484. doi: 10.2169/internalmedicine.1673-18. Epub 2019 May 15. Intern Med. 2019. PMID: 31092773 Free PMC article.
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).
Tanaka H, Sakamoto H, Akita T, Ohyanagi F, Kawashima Y, Tambo Y, Tanimoto A, Horiike A, Miyauchi E, Tsuchiya-Kawano Y, Yanagitani N, Nishio M. Tanaka H, et al. Among authors: ohyanagi f. Thorac Cancer. 2022 May;13(10):1471-1478. doi: 10.1111/1759-7714.14415. Epub 2022 Apr 12. Thorac Cancer. 2022. PMID: 35415873 Free PMC article.
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer.
Saiki M, Kitazono S, Yoshizawa T, Dotsu Y, Ariyasu R, Koyama J, Sonoda T, Uchibori K, Nishikawa S, Yanagitani N, Horiike A, Ohyanagi F, Oikado K, Ninomiya H, Takeuchi K, Ishikawa Y, Nishio M. Saiki M, et al. Among authors: ohyanagi f. Clin Lung Cancer. 2018 Sep;19(5):435-440.e1. doi: 10.1016/j.cllc.2018.04.006. Epub 2018 May 10. Clin Lung Cancer. 2018. PMID: 29885946
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.
Kasai T, Mori K, Sugiyama T, Koyama N, Nakamura Y, Ohyanagi F, Fukuda H, Hoshi E, Kobayashi K, Nakayama M. Kasai T, et al. Among authors: ohyanagi f. Int J Clin Oncol. 2022 Dec;27(12):1841-1848. doi: 10.1007/s10147-022-02241-6. Epub 2022 Oct 14. Int J Clin Oncol. 2022. PMID: 36241930 Clinical Trial.
55 results